Carl Zeiss Meditec AG (CHIX:AFXD) Cyclically Adjusted PB Ratio: (As of Jul. 17, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

CHIX:AFXD Carl Zeiss Meditec AG CHIX:AFXD
65 GF Score
Price €28.73
GF Value €70.18
Valuation Significantly Undervalued
! 4 Warning Signs
View Full Analysis

What is Carl Zeiss Meditec AG Cyclically Adjusted PB Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Carl Zeiss Meditec AG  (CHIX:AFXd) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Carl Zeiss Meditec AG Cyclically Adjusted PB Ratio Related Terms


Carl Zeiss Meditec AG Cyclically Adjusted PB Ratio Historical Data

* Premium members only.

The historical data trend for Carl Zeiss Meditec AG's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Carl Zeiss Meditec AG Cyclically Adjusted PB Ratio Chart

Carl Zeiss Meditec AG Annual Data
Trend Sep16 Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 14.19 7.80 5.28 4.08 2.16

Carl Zeiss Meditec AG Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 3.28 0.00 2.16 0.00

CHIX:AFXD vs ISRG, BDX, MDLN: Cyclically Adjusted PB Ratio Comparison

For the Medical Instruments & Supplies subindustry, Carl Zeiss Meditec AG's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Carl Zeiss Meditec AG Cyclically Adjusted PB Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Carl Zeiss Meditec AG's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Carl Zeiss Meditec AG's Cyclically Adjusted PB Ratio falls into.


CHIX:AFXD
65GF Score
Carl Zeiss Meditec AG CHIX:AFXD
Cyclically Adjusted PB Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Carl Zeiss Meditec AG Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Carl Zeiss Meditec AG's Cyclically Adjusted Book per Share for the quarter that ended in Dec. 2025 is calculated as:

For example, Carl Zeiss Meditec AG's adjusted Book Value per Share data for the three months ended in Dec. 2025 was:

Adj_Book=Book Value per Share/CPI of Dec. 2025 (Change)*Current CPI (Dec. 2025)
=0/129.3606*129.3606
=0.000

Current CPI (Dec. 2025) = 129.3606.

Carl Zeiss Meditec AG Quarterly Data

Book Value per Share CPI Adj_Book
201603 9.682 100.017 12.523
201606 9.511 100.717 12.216
201609 9.812 101.017 12.565
201612 0.000 101.217 0.000
201703 13.401 101.417 17.093
201706 0.000 102.117 0.000
201709 13.589 102.717 17.114
201712 0.000 102.617 0.000
201803 14.088 102.917 17.708
201806 0.000 104.017 0.000
201809 14.462 104.718 17.865
201812 0.000 104.217 0.000
201903 14.601 104.217 18.124
201906 0.000 105.718 0.000
201909 15.635 106.018 19.078
201912 0.000 105.818 0.000
202003 16.293 105.718 19.937
202006 0.000 106.618 0.000
202009 16.007 105.818 19.568
202012 0.000 105.518 0.000
202103 17.280 107.518 20.791
202106 0.000 108.486 0.000
202109 18.552 109.435 21.930
202112 0.000 110.384 0.000
202203 19.425 113.968 22.049
202206 0.000 115.760 0.000
202209 22.530 118.818 24.529
202212 0.000 119.345 0.000
202303 21.943 122.402 23.190
202306 0.000 123.140 0.000
202309 24.144 124.195 25.148
202312 0.000 123.773 0.000
202403 23.924 125.038 24.751
202406 0.000 125.882 0.000
202409 23.324 126.198 23.909
202412 0.000 127.041 0.000
202503 23.715 127.779 24.008
202506 0.000 128.412 0.000
202509 24.179 129.255 24.199
202512 0.000 129.361 0.000

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

Is Carl Zeiss Meditec AG (CHIX:AFXD) Overvalued in 2026?

Based on GuruFocus' analysis, Carl Zeiss Meditec AG stock appears to be undervalued. The current stock price of €28.73 is trading 59.1% below its estimated GF Value™ of €70.18. GuruFocus considers Carl Zeiss Meditec AG to be Significantly Undervalued.

Key valuation signals for CHIX:AFXD:

  • Cyclically Adjusted PB Ratio:
  • GF Value™: €70.18 vs. price of €28.73 (59.1% below fair value)
  • GF Score™: 65/100 with 4 warning signs

No single metric tells the full story. See the CHIX:AFXD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Carl Zeiss Meditec AG Business Description

Address Goschwitzer Strasse 51-52, Jena, TH, DEU, 07745
Carl Zeiss Meditec is one of the largest visioncare technology companies in the world, and it operates in two segments: ophthalmic devices and microsurgery. OPT, which made up about 75% of sales in 2025, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, as well as a portfolio of intraocular lenses and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. MCS is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% market share, Zeiss is the clear leader in the microsurgery space.
65GF Score

Get the complete analysis for CHIX:AFXD

Cyclically Adjusted PB Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€28.73
Price
€70.18
GF Value